GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tauns Laboratories Inc (TSE:197A) » Definitions » ROE % Adjusted to Book Value

Tauns Laboratories (TSE:197A) ROE % Adjusted to Book Value : 17.37% (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Tauns Laboratories ROE % Adjusted to Book Value?

Tauns Laboratories's ROE % for the quarter that ended in Jun. 2024 was 52.12%. Tauns Laboratories's PB Ratio for the quarter that ended in Jun. 2024 was 3.00. Tauns Laboratories's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was 17.37%.


Tauns Laboratories ROE % Adjusted to Book Value Historical Data

The historical data trend for Tauns Laboratories's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tauns Laboratories ROE % Adjusted to Book Value Chart

Tauns Laboratories Annual Data
Trend Jun22 Jun23 Jun24
ROE % Adjusted to Book Value
- - 17.37

Tauns Laboratories Semi-Annual Data
Jun22 Jun23 Jun24
ROE % Adjusted to Book Value - - 17.37

Competitive Comparison of Tauns Laboratories's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, Tauns Laboratories's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tauns Laboratories's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tauns Laboratories's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Tauns Laboratories's ROE % Adjusted to Book Value falls into.


;
;

Tauns Laboratories ROE % Adjusted to Book Value Calculation

Tauns Laboratories's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=52.12% / 3.00
=17.37%

Tauns Laboratories's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=52.12% / 3.00
=17.37%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tauns Laboratories ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Tauns Laboratories's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Tauns Laboratories Business Description

Traded in Other Exchanges
N/A
Address
761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.

Tauns Laboratories Headlines

No Headlines